Manage the hidden driver of your healthcare spend.
Late-stage skin cancer is a preventable high-cost claim. Our Direct Access Platform™ gives you the upper hand by identifying skin cancer at its earliest, most affordable stage—protecting your employees and your bottom line.
Better outcomes. Lower costs. No major lift.
Explore how CheckMySpot® helps manage claims risk while reducing HR burden.
CheckMySpot®’s cost savings are independently validated by the respected Validation Institute—demonstrating strong ROI, reduced direct healthcare costs, and faster access to treatment so employees stay healthy and return to work sooner.
We handle eligibility, compliance, administration, and care coordination so your HR team doesn’t have to.
When a spot is indeterminate or worrisome, CheckMySpot expedites referrals to board-certified dermatologists and monitors appointment availability to ensure timely care. By accelerating the path from detection to treatment, we help reduce delays that can lead to higher costs and more serious outcomes.
Early detection transforms six-figure claims into minimal costs while improving outcomes and saving lives.
Differentiate your benefits package while boosting employee trust, retention, and overall satisfaction.
See how CheckMySpot® can add value to your organization.
Certified dermatologist feedback in just a few taps.
Our app makes it easy for employees to get the answers they need anytime, anywhere.
Frequently Asked Questions
Skin cancer is the most commonly diagnosed cancer in the U.S., with over 6 million cases treated each year. It represents a high-frequency, recurring source of claims in employer-sponsored health plans.
6M+ cases treated annually
Skin cancer claims costs vary significantly by stage. Early-stage cases may cost $2,000–$14,000, while advanced-stage melanoma can exceed $100,000 per year. This makes early detection and treatment critical for reducing claims spend.
Skin cancer is a major cost driver because of its high frequency and escalating treatment costs. With millions of cases each year and an 8.9 billion U.S. annual spend, even moderate per-case expenses add up quickly, especially for late stage skin cancers.
Yes, Outdoor workers face a ~60% higher risk due to prolonged UV exposure. 1 in 3 deaths from nonmelanoma skin cancer is linked to occupational exposure, making early detection and treatment especially critical.
1 in 3 deaths linked to occupational exposure
The ROI of skin cancer management comes from catching and treating skin cancer earlier, when treatment is far less expensive. Early-stage cases may cost a few thousand dollars, while late-stage melanoma can exceed $100,000. By prioritizing early detection and treatment, employers can reduce high-cost claims, lower overall healthcare spend, and improve employee outcomes.
Late-stage: $100K+
→ Massive cost avoidance potential
CheckMySpot® reduces claims costs by combining early detection with fast-tracked treatment. Employees receive quick evaluations from anywhere, and if a spot looks concerning, they are immediately directed to in-person care. This helps catch and treat skin cancer earlier, when costs are significantly lower.
+ Faster treatment
= Fewer high-cost late-stage claims
CheckMySpot® removes common barriers to care like long wait times and missed workdays. Employees get answers in days, not months. And when something looks concerning, they are quickly transferred to in-person care.
CheckMySpot® improves engagement by making screening simple, fast, and accessible from anywhere. This enables more employees to receive screenings—increasing early detection rates and lowering claims costs for employers.
→ Fewer delays
→ Higher engagement
